OMEICOS Therapeutics GmbH - Founders


Dr. Wolf-Hagen Schunck, MDC Berlin, BoD member OMEICOS 


35 years of research experience, 100 publications

Research focus: Cytochrome P450 (CYP)-dependent metabolism of n-6 and n-3 PUFAs; CYP-eicosanoids in regulation of vascular, renal and cardiac function

Prof. Dr. John R. Falck, UT Southwestern 


40 years of research experience, 600 publications

Research focus: Role of Eicosanoids in renal function; Synthesis and function of novel eicosanoid analogs; Co-founder and board member in several biotech ventures

Dr. Robert Fischer, CEO, CSO OMEICOS 


12 years clinical and basic research experience

Research focus: Molecular mechanims of arrhythmia; Clinical focus: human arrhythmias, experience as principal and sub-investigator in cardiovascular trials

Prof. Dr. Dominik Müller, MDC Berlin 


20 years of research experience, 155 publications

Research focus: Cardiovascular hormones and hypertension-induced target organ damage,

role of epigenetic factors on immune response in target organ damage